Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sandeep Gedela
Institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital
Observed institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Post Graduate Institute of Medical Education and Research
ORCID:
0000-0001-7528-187X
Observed ORCID:
0000-0001-7528-187X
OpenAlex ID:
A5065395419
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII)
2026
·
Vanita Noronha
, Vijay Patil
, et al.
·
Journal of Clinical Oncology
·
25
Gemcitabine, Cisplatin, and Nab-Paclitaxel as a First-Line Therapy for Advanced Biliary Tract Cancers
2023
·
Sandeep Gedela
, Pritesh Munot
, et al.
·
Journal of Gastrointestinal Cancer
·
10
Comparative analyses of paclitaxel/carboplatin with cisplatin/5-fluorouracil-based chemoradiation in locally advanced inoperable upper and middle third esophageal cancer: A randomized prospective pilot study
2022
·
Divyesh Kumar
, Treshita Dey
, et al.
·
Journal of Cancer Research and Therapeutics
·
3
Outcomes and toxicities of triple metronomic chemotherapy with low-dose nivolumab and axitinib in unresectable, recurrent, and metastatic head-and-neck squamous cell carcinomas: A real-world retrospective analysis from a resource-constrained setting
2026
·
Rumeli Roy
, Vanita Noronha
, et al.
·
Cancer Research Statistics and Treatment
·
1
Clinical outcomes with low-dose lorlatinib in ALK mutation–positive metastatic lung adenocarcinoma: Experience from a tertiary care center in a developing country.
2026
·
Sandeep Gedela
, Vanita Noronha
, et al.
·
Journal of Clinical Oncology
Adenocarcinoma of Mammary Gland Type of the Vulva
2026
·
Gauri Nakra
, Aishwarya Sharma
, et al.
·
International Journal of Surgical Pathology
Show more works
View as search
Works count:
6
Citation count:
39
H-index:
3
I10-index:
2
Year
Topic
Type